Neuroendocrine Tumor Treatment Market Report

China Neuroendocrine Tumor Treatment Industry Market Research Report 2023-2029

  • POSTDATE：Sep 07, 2023
  • PAGES：233
  • REPORT CODE：GMM1781800
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Neuroendocrine Tumor Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Ipsen Pharma

    • Tarveda Therapeutics

    • AVEO Pharmaceuticals, Inc

    • Hutchison MediPharma Limited

    • Boehringer Ingelheim International GmbH

    • Progenics Pharmaceuticals, Inc

    • Novartis AG

    • Advanced Accelerator Applications

    By Type:

    • Targeted Therapy

    • Others

    • Somatostatin Analogs (SSAs)

    By Application:

    • Lungs

    • Colon

    • Small Intestine

    • Others

    • Pancreas

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Neuroendocrine Tumor Treatment Market Overview 2018-2029

    • 1.1 China Neuroendocrine Tumor Treatment Industry Development Overview

    • 1.2 China Neuroendocrine Tumor Treatment Industry Development History

    • 1.3 China Neuroendocrine Tumor Treatment Industry Market Size (2018-2029)

    • 1.4 China Neuroendocrine Tumor Treatment Market Analysis by Type from Production Side

      • 1.4.1 China Neuroendocrine Tumor Treatment Production Volume, Production Value and Growth Rate of Targeted Therapy (2018-2029)

      • 1.4.2 China Neuroendocrine Tumor Treatment Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.3 China Neuroendocrine Tumor Treatment Production Volume, Production Value and Growth Rate of Somatostatin Analogs (SSAs) (2018-2029)

    • 1.5 China Neuroendocrine Tumor Treatment Market Analysis by Application from Consumption End

      • 1.5.1 China Neuroendocrine Tumor Treatment Sales Volume, Sales Value and Growth Rate of Lungs (2018-2029)

      • 1.5.2 China Neuroendocrine Tumor Treatment Sales Volume, Sales Value and Growth Rate of Colon (2018-2029)

      • 1.5.3 China Neuroendocrine Tumor Treatment Sales Volume, Sales Value and Growth Rate of Small Intestine (2018-2029)

      • 1.5.4 China Neuroendocrine Tumor Treatment Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.5 China Neuroendocrine Tumor Treatment Sales Volume, Sales Value and Growth Rate of Pancreas (2018-2029)

    • 1.6 China Neuroendocrine Tumor Treatment Market Analysis by Region

      • 1.6.1 North China Neuroendocrine Tumor Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Neuroendocrine Tumor Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Neuroendocrine Tumor Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Neuroendocrine Tumor Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Neuroendocrine Tumor Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Neuroendocrine Tumor Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Neuroendocrine Tumor Treatment Market Size and Growth Rate from 2018-2029

    Chapter 2 China Neuroendocrine Tumor Treatment Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Neuroendocrine Tumor Treatment Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Neuroendocrine Tumor Treatment Market Status and Competition Analysis in 2023

      • 2.2.3 China Neuroendocrine Tumor Treatment Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Neuroendocrine Tumor Treatment Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Neuroendocrine Tumor Treatment Industry Development

    Chapter 3 Neuroendocrine Tumor TreatmentIndustry Chain Analysis

    • 3.1 Neuroendocrine Tumor Treatment Industry Chain

    • 3.2 Neuroendocrine Tumor Treatment Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Neuroendocrine Tumor Treatment Market

    • 3.3 Neuroendocrine Tumor Treatment Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Neuroendocrine Tumor Treatment Market

    Chapter 4 China Neuroendocrine Tumor Treatment Market, by Type

    • 4.1 China Neuroendocrine Tumor Treatment Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Neuroendocrine Tumor Treatment Total Production Volume and Growth Rate from Production Side

    • 4.5 China Neuroendocrine Tumor Treatment Production Volume and Growth Rate, by Type

      • 4.5.1 China Neuroendocrine Tumor Treatment Production Volume and Growth Rate of Targeted Therapy

      • 4.5.2 China Neuroendocrine Tumor Treatment Production Volume and Growth Rate of Others

      • 4.5.3 China Neuroendocrine Tumor Treatment Production Volume and Growth Rate of Somatostatin Analogs (SSAs)

    Chapter 5 China Neuroendocrine Tumor Treatment Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Neuroendocrine Tumor Treatment Total Market Size and Growth Rate from Consumption End

    • 5.5 China Neuroendocrine Tumor Treatment Market Size and Growth Rate, by Application

      • 5.5.1 China Neuroendocrine Tumor Treatment Market Size and Growth Rate of Lungs

      • 5.5.2 China Neuroendocrine Tumor Treatment Market Size and Growth Rate of Colon

      • 5.5.3 China Neuroendocrine Tumor Treatment Market Size and Growth Rate of Small Intestine

      • 5.5.4 China Neuroendocrine Tumor Treatment Market Size and Growth Rate of Others

      • 5.5.5 China Neuroendocrine Tumor Treatment Market Size and Growth Rate of Pancreas

    Chapter 6 China Neuroendocrine Tumor Treatment Market, by Region

    • 6.1 China Neuroendocrine Tumor Treatment Production Volume and Production Value, by Region

    • 6.2 China Neuroendocrine Tumor Treatment Sales Volume and Sales Value, by Region

    Chapter 7 North China Neuroendocrine Tumor Treatment Market Analysis

    • 7.1 North China Neuroendocrine Tumor Treatment Market, by Type

    • 7.2 North China Neuroendocrine Tumor Treatment Market, by Application

    Chapter 8 Central China Neuroendocrine Tumor Treatment Market Analysis

    • 8.1 Central China Neuroendocrine Tumor Treatment Market, by Type

    • 8.2 Central China Neuroendocrine Tumor Treatment Market, by Application

    Chapter 9 South China Neuroendocrine Tumor Treatment Market Analysis

    • 9.1 South China Neuroendocrine Tumor Treatment Market, by Type

    • 9.2 South China Neuroendocrine Tumor Treatment Market, by Application

    Chapter 10 East China Neuroendocrine Tumor Treatment Market Analysis

    • 10.1 East China Neuroendocrine Tumor Treatment Market, by Type

    • 10.2 East China Neuroendocrine Tumor Treatment Market, by Application

    Chapter 11 Northeast China Neuroendocrine Tumor Treatment Market Analysis

    • 11.1 Northeast China Neuroendocrine Tumor Treatment Market, by Type

    • 11.2 Northeast China Neuroendocrine Tumor Treatment Market, by Application

    Chapter 12 Southwest China Neuroendocrine Tumor Treatment Market Analysis

    • 12.1 Southwest China Neuroendocrine Tumor Treatment Market, by Type

    • 12.2 Southwest China Neuroendocrine Tumor Treatment Market, by Application

    Chapter 13 Northwest China Neuroendocrine Tumor Treatment Market Analysis

    • 13.1 Northwest China Neuroendocrine Tumor Treatment Market, by Type

    • 13.2 Northwest China Neuroendocrine Tumor Treatment Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Ipsen Pharma

        • 14.1.1 Ipsen Pharma Company Profile

        • 14.1.2 Ipsen Pharma Neuroendocrine Tumor Treatment Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Tarveda Therapeutics

        • 14.2.1 Tarveda Therapeutics Company Profile

        • 14.2.2 Tarveda Therapeutics Neuroendocrine Tumor Treatment Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 AVEO Pharmaceuticals, Inc

        • 14.3.1 AVEO Pharmaceuticals, Inc Company Profile

        • 14.3.2 AVEO Pharmaceuticals, Inc Neuroendocrine Tumor Treatment Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Hutchison MediPharma Limited

        • 14.4.1 Hutchison MediPharma Limited Company Profile

        • 14.4.2 Hutchison MediPharma Limited Neuroendocrine Tumor Treatment Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Boehringer Ingelheim International GmbH

        • 14.5.1 Boehringer Ingelheim International GmbH Company Profile

        • 14.5.2 Boehringer Ingelheim International GmbH Neuroendocrine Tumor Treatment Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Progenics Pharmaceuticals, Inc

        • 14.6.1 Progenics Pharmaceuticals, Inc Company Profile

        • 14.6.2 Progenics Pharmaceuticals, Inc Neuroendocrine Tumor Treatment Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Novartis AG

        • 14.7.1 Novartis AG Company Profile

        • 14.7.2 Novartis AG Neuroendocrine Tumor Treatment Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Advanced Accelerator Applications

        • 14.8.1 Advanced Accelerator Applications Company Profile

        • 14.8.2 Advanced Accelerator Applications Neuroendocrine Tumor Treatment Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Neuroendocrine Tumor Treatment Industry Research Conclusions

    • 15.2 Neuroendocrine Tumor Treatment Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Neuroendocrine Tumor Treatment Industry Market Size (2018-2029)

    • Figure China Neuroendocrine Tumor Treatment Production Volume, Production Value and Growth Rate of Targeted Therapy (2018-2029)

    • Figure China Neuroendocrine Tumor Treatment Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Neuroendocrine Tumor Treatment Production Volume, Production Value and Growth Rate of Somatostatin Analogs (SSAs) (2018-2029)

    • Figure China Neuroendocrine Tumor Treatment Sales Volume, Sales Value and Growth Rate of Lungs (2018-2029)

    • Figure China Neuroendocrine Tumor Treatment Sales Volume, Sales Value and Growth Rate of Colon (2018-2029)

    • Figure China Neuroendocrine Tumor Treatment Sales Volume, Sales Value and Growth Rate of Small Intestine (2018-2029)

    • Figure China Neuroendocrine Tumor Treatment Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Neuroendocrine Tumor Treatment Sales Volume, Sales Value and Growth Rate of Pancreas (2018-2029)

    • Figure North China Neuroendocrine Tumor Treatment Market Size and Growth Rate from 2018-2029

    • Figure Central China Neuroendocrine Tumor Treatment Market Size and Growth Rate from 2018-2029

    • Figure South China Neuroendocrine Tumor Treatment Market Size and Growth Rate from 2018-2029

    • Figure East China Neuroendocrine Tumor Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Neuroendocrine Tumor Treatment Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Neuroendocrine Tumor Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Neuroendocrine Tumor Treatment Market Size and Growth Rate from 2018-2029

    • Figure Neuroendocrine Tumor Treatment Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Neuroendocrine Tumor Treatment Market Share by Type in 2018

    • Figure China Neuroendocrine Tumor Treatment Market Share by Type in 2023

    • Figure China Neuroendocrine Tumor Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Neuroendocrine Tumor Treatment Production Volume and Growth Rate of Targeted Therapy (2018-2023)

    • Figure China Neuroendocrine Tumor Treatment Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Neuroendocrine Tumor Treatment Production Volume and Growth Rate of Somatostatin Analogs (SSAs) (2018-2023)

    • Figure China Neuroendocrine Tumor Treatment Market Share by Application in 2018

    • Figure China Neuroendocrine Tumor Treatment Market Share by Application in 2023

    • Figure China Neuroendocrine Tumor Treatment Total Market Size and Growth Rate from Consumption End

    • Figure China Neuroendocrine Tumor Treatment Market Size and Growth Rate of Lungs (2018-2023)

    • Figure China Neuroendocrine Tumor Treatment Market Size and Growth Rate of Colon (2018-2023)

    • Figure China Neuroendocrine Tumor Treatment Market Size and Growth Rate of Small Intestine (2018-2023)

    • Figure China Neuroendocrine Tumor Treatment Market Size and Growth Rate of Others (2018-2023)

    • Figure China Neuroendocrine Tumor Treatment Market Size and Growth Rate of Pancreas (2018-2023)

    • Table China Neuroendocrine Tumor Treatment Production Volume by Region (2018-2023)

    • Table China Neuroendocrine Tumor Treatment Production Volume Share by Region (2018-2023)

    • Figure China Neuroendocrine Tumor Treatment Production Volume Share by Region (2018-2023)

    • Table China Neuroendocrine Tumor Treatment Production Value by Region (2018-2023)

    • Table China Neuroendocrine Tumor Treatment Production Value Share by Region (2018-2023)

    • Figure China Neuroendocrine Tumor Treatment Production Value Share by Region (2018-2023)

    • Table China Neuroendocrine Tumor Treatment Sales Volume by Region (2018-2023)

    • Table China Neuroendocrine Tumor Treatment Sales Volume Share by Region (2018-2023)

    • Figure China Neuroendocrine Tumor Treatment Sales Volume Share by Region (2018-2023)

    • Table China Neuroendocrine Tumor Treatment Sales Value by Region (2018-2023)

    • Table China Neuroendocrine Tumor Treatment Sales Value Share by Region (2018-2023)

    • Figure China Neuroendocrine Tumor Treatment Sales Value Share by Region (2018-2023)

    • Table North China Neuroendocrine Tumor Treatment Production Volume by Type (2018-2023)

    • Table North China Neuroendocrine Tumor Treatment Production Volume Share by Type (2018-2023)

    • Figure North China Neuroendocrine Tumor Treatment Production Volume Share by Type (2018-2023)

    • Table North China Neuroendocrine Tumor Treatment Sales Volume by Application (2018-2023)

    • Table North China Neuroendocrine Tumor Treatment Sales Volume Share by Application (2018-2023)

    • Figure North China Neuroendocrine Tumor Treatment Sales Volume Share by Application (2018-2023)

    • Table Central China Neuroendocrine Tumor Treatment Production Volume by Type (2018-2023)

    • Table Central China Neuroendocrine Tumor Treatment Production Volume Share by Type (2018-2023)

    • Figure Central China Neuroendocrine Tumor Treatment Production Volume Share by Type (2018-2023)

    • Table Central China Neuroendocrine Tumor Treatment Sales Volume by Application (2018-2023)

    • Table Central China Neuroendocrine Tumor Treatment Sales Volume Share by Application (2018-2023)

    • Figure Central China Neuroendocrine Tumor Treatment Sales Volume Share by Application (2018-2023)

    • Table South China Neuroendocrine Tumor Treatment Production Volume by Type (2018-2023)

    • Table South China Neuroendocrine Tumor Treatment Production Volume Share by Type (2018-2023)

    • Figure South China Neuroendocrine Tumor Treatment Production Volume Share by Type (2018-2023)

    • Table South China Neuroendocrine Tumor Treatment Sales Volume by Application (2018-2023)

    • Table South China Neuroendocrine Tumor Treatment Sales Volume Share by Application (2018-2023)

    • Figure South China Neuroendocrine Tumor Treatment Sales Volume Share by Application (2018-2023)

    • Table East China Neuroendocrine Tumor Treatment Production Volume by Type (2018-2023)

    • Table East China Neuroendocrine Tumor Treatment Production Volume Share by Type (2018-2023)

    • Figure East China Neuroendocrine Tumor Treatment Production Volume Share by Type (2018-2023)

    • Table East China Neuroendocrine Tumor Treatment Sales Volume by Application (2018-2023)

    • Table East China Neuroendocrine Tumor Treatment Sales Volume Share by Application (2018-2023)

    • Figure East China Neuroendocrine Tumor Treatment Sales Volume Share by Application (2018-2023)

    • Table Northeast China Neuroendocrine Tumor Treatment Production Volume by Type (2018-2023)

    • Table Northeast China Neuroendocrine Tumor Treatment Production Volume Share by Type (2018-2023)

    • Figure Northeast China Neuroendocrine Tumor Treatment Production Volume Share by Type (2018-2023)

    • Table Northeast China Neuroendocrine Tumor Treatment Sales Volume by Application (2018-2023)

    • Table Northeast China Neuroendocrine Tumor Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Neuroendocrine Tumor Treatment Sales Volume Share by Application (2018-2023)

    • Table Southwest China Neuroendocrine Tumor Treatment Production Volume by Type (2018-2023)

    • Table Southwest China Neuroendocrine Tumor Treatment Production Volume Share by Type (2018-2023)

    • Figure Southwest China Neuroendocrine Tumor Treatment Production Volume Share by Type (2018-2023)

    • Table Southwest China Neuroendocrine Tumor Treatment Sales Volume by Application (2018-2023)

    • Table Southwest China Neuroendocrine Tumor Treatment Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Neuroendocrine Tumor Treatment Sales Volume Share by Application (2018-2023)

    • Table Northwest China Neuroendocrine Tumor Treatment Production Volume by Type (2018-2023)

    • Table Northwest China Neuroendocrine Tumor Treatment Production Volume Share by Type (2018-2023)

    • Figure Northwest China Neuroendocrine Tumor Treatment Production Volume Share by Type (2018-2023)

    • Table Northwest China Neuroendocrine Tumor Treatment Sales Volume by Application (2018-2023)

    • Table Northwest China Neuroendocrine Tumor Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Neuroendocrine Tumor Treatment Sales Volume Share by Application (2018-2023)

    • Table Ipsen Pharma Company Profile

    • Table Ipsen Pharma Neuroendocrine Tumor Treatment Revenue, Price and Gross (2018-2023)

    • Table Tarveda Therapeutics Company Profile

    • Table Tarveda Therapeutics Neuroendocrine Tumor Treatment Revenue, Price and Gross (2018-2023)

    • Table AVEO Pharmaceuticals, Inc Company Profile

    • Table AVEO Pharmaceuticals, Inc Neuroendocrine Tumor Treatment Revenue, Price and Gross (2018-2023)

    • Table Hutchison MediPharma Limited Company Profile

    • Table Hutchison MediPharma Limited Neuroendocrine Tumor Treatment Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim International GmbH Company Profile

    • Table Boehringer Ingelheim International GmbH Neuroendocrine Tumor Treatment Revenue, Price and Gross (2018-2023)

    • Table Progenics Pharmaceuticals, Inc Company Profile

    • Table Progenics Pharmaceuticals, Inc Neuroendocrine Tumor Treatment Revenue, Price and Gross (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Neuroendocrine Tumor Treatment Revenue, Price and Gross (2018-2023)

    • Table Advanced Accelerator Applications Company Profile

    • Table Advanced Accelerator Applications Neuroendocrine Tumor Treatment Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US